1. 5PSQ-019 An organisational approach to improve the safety of intravenous potassium chloride replacement: data from a tertiary care hospital. (2nd March 2018) Authors: Fakhir, J; Ghanem, W Abi; Ramia, E; Khoury, C El; Issa, S; Skayem, N Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diffusion effects in nonlinear dynamics of hepatitis B virus. (12th July 2021) Authors: Issa, S; Mbopda Tamko, B; Dabolé, B; Tabi, C B; Fouda Ekobena, H P Journal: Physica scripta Issue: Volume 96:Number 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS03.6.A Rituximab in primary CNS lymphoma - long term follow-up of the phase III HOVON 105/ALLG NHL 24 Study. (5th September 2022) Authors: Bromberg, J E C; Issa, S; van der Holt, B; Minnema, M C; Seute, T; Durian, M F; Cull, G; van der Poel, M W M; Stevens, W B C; Zijlstra, J M; Nijland, M; Mason, K D; Beeker, A; Brandsma, D; van den Bent, M J; Gonzalez, M; de Jong, D; Doorduijn, J K Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS2.5 Effect of rituximab in primary central nervous system lymphoma - results of the randomized phase III HOVON 105/ALLG NHL 24 study. (19th September 2018) Authors: Bromberg, J E C; Issa, S; Bakunina, K; Minnema, M C; Seute, T; Cull, G; van den Bent, M J; Gonzales, M; de Jong, D; Doorduijn, J K Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS2.5 Effect of rituximab in primary central nervous system lymphoma - results of the randomized phase III HOVON 105/ALLG NHL 24 study. (19th September 2018) Authors: Bromberg, J E C; Issa, S; Bakunina, K; Minnema, M C; Seute, T; Cull, G; van den Bent, M J; Gonzales, M; de Jong, D; Doorduijn, J K Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OS7.1 Impact of the addition of Rituximab to standard therapy with high dose methotrexate on health-related quality of life in primary central nervous system lymphoma patients. (6th September 2019) Authors: van der Meulen, M; Dirven, L; Bakunina, K; Taphoorn, M J B; van den Bent, M J; Issa, S; Doorduijn, J K; Bromberg, J E C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PILOTING A RAPID ASSESSMENT TOOL IN CHILDREN'S ED. Issue 12 (18th November 2016) Authors: Issa, S; Cole, R; Alcock, A; Sajjanhar, T; Selby, N Journal: Emergency medicine journal Issue: Volume 33:Issue 12(2016) Page Start: 898 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THE ACCURACY OF EXISTING PRE-HOSPITAL TRIAGE TOOLS FOR INJURED CHILDREN IN ENGLAND–AN ANALYSIS USING TRAUMA REGISTRY AND EMERGENCY DEPARTMENT DATA. Issue 10 (7th September 2013) Authors: Cheung, R; Ardolino, A; Lawrence, T; Bouamra, O; Lecky, F E; Berry, K; Chaudhury, A; Issa, S; Koralage, N; Lyttle, M D; Maconochie, I K Journal: Emergency medicine journal Issue: Volume 30:Issue 10(2013) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗